Clinical trials
Active, not recruiting Phase 1/2 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| 23andMe, Inc. | 1 |
| Adicet Therapeutics | 1 |
| Ajjai Alva, MD | 1 |
| Arsenal Biosciences, Inc. | 1 |
| BeiGene | 1 |
| Beijing Scitech-Mq Pharmaceuticals Limited | 1 |
| Dan Zandberg | 1 |
| Fox Chase Cancer Center | 1 |
| Hao Zeng | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 21 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Melanoma | 6 |
| Kidney Neoplasms | 4 |
| Carcinoma, Transitional Cell | 3 |
| Small Cell Lung Carcinoma | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Carcinoma, Ovarian Epithelial | 2 |
| Colorectal Neoplasms | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.